Histone deacetylase inhibitors mediate post-transcriptional regulation of p21 WAF1 through novel cis-acting elements in the 3′ untranslated region

Biochemical and Biophysical Research Communications

Volumn 402, Issue 4, 2010, Pages 687-692

  Hirsch, Calley L ^a   Ellis, Danielle J P ^a   Bonham, Keith ^b  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

3 untranslated region; Histone deacetylase inhibitors; MRNA stability; P21 WAF1

Indexed keywords

CIS ACTING ELEMENT; CYCLIN DEPENDENT KINASE INHIBITOR 1; HISTONE DEACETYLASE INHIBITOR; MESSENGER RNA; TRICHOSTATIN A;

3' UNTRANSLATED REGION; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; PRIORITY JOURNAL; RNA STABILITY; TRANSCRIPTION REGULATION;

3' UNTRANSLATED REGIONS; ANIMALS; ANTINEOPLASTIC AGENTS; BASE SEQUENCE; CELL LINE, TUMOR; CYCLIN-DEPENDENT KINASE INHIBITOR P21; GENE EXPRESSION REGULATION; HISTONE DEACETYLASE INHIBITORS; HUMANS; MICE; MOLECULAR SEQUENCE DATA; REGULATORY ELEMENTS, TRANSCRIPTIONAL; RNA STABILITY; TRANSCRIPTION, GENETIC;

EID: 78649446590     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.10.085     Document Type: Article

References (33)

1. Frew A.J., Johnstone R.W., Bolden J.E. Enhancing the apoptotic and therapeutic effects of HDAC inhibitors. Cancer Lett. 2009, 280:125-133.
2. Garber K. HDAC inhibitors Overcome first hurdle. Nat. Biotechnol. 2007, 25:17-19.
3. Van Lint C., Emiliani S., Verdin E. The expression of a small fraction of cellular genes is changed in response to histone hyperacetylation. Gene Expr. 1996, 5:245-253.
4. Mariadason J.M., Corner G.A., Augenlicht L.H. Genetic reprogramming in pathways of colonic cell maturation induced by short chain fatty acids: comparison with trichostatin A, sulindac, and curcumin and implications for chemoprevention of colon cancer. Cancer Res. 2000, 60:4561-4572.
5. Kostyniuk C.L., Dehm S.M., Batten D., Bonham K. The ubiquitous and tissue specific promoters of the human SRC gene are repressed by inhibitors of histone deacetylases. Oncogene 2002, 21:6340-6347.
6. Jung Y.S., Qian Y., Chen X. Examination of the expanding pathways for the regulation of p21 expression and activity. Cell Signal. 2010, 22:1003-1012.
7. Archer S.Y., Meng S., Shei A., Hodin R.A. p21(WAF1) is required for butyrate-mediated growth inhibition of human colon cancer cells. Proc. Natl. Acad. Sci. USA 1998, 95:6791-6796.
8. Rosato R.R., Wang Z., Gopalkrishnan R.V., Fisher P.B., Grant S. Evidence of a functional role for the cyclin-dependent kinase-inhibitor p21WAF1/CIP1/MDA6 in promoting differentiation and preventing mitochondrial dysfunction and apoptosis induced by sodium butyrate in human myelomonocytic leukemia cells (U937). Int. J. Oncol. 2001, 19:181-191.
9. Nakano K., Mizuno T., Sowa Y., Orita T., Yoshino T., Okuyama Y., Fujita T., Ohtani-Fujita N., Matsukawa Y., Tokino T., Yamagishi H., Oka T., Nomura H., Sakai T. Butyrate activates the WAF1/Cip1 gene promoter through Sp1 sites in a p53-negative human colon cancer cell line. J. Biol. Chem. 1997, 272:22199-22206.
10. Sowa Y., Orita T., Minamikawa S., Nakano K., Mizuno T., Nomura H., Sakai T. Histone deacetylase inhibitor activates the WAF1/Cip1 gene promoter through the Sp1 sites. Biochem. Biophys. Res. Commun. 1997, 241:142-150.
11. Hirsch C.L., Bonham K. Histone deacetylase inhibitors regulate p21WAF1 gene expression at the post-transcriptional level in HepG2 cells. FEBS Lett. 2004, 570:37-40.
12. Li X.S., Rishi A.K., Shao Z.M., Dawson M.I., Jong L., Shroot B., Reichert U., Ordonez J., Fontana J.A. Posttranscriptional regulation of p21WAF1/CIP1 expression in human breast carcinoma cells. Cancer Res. 1996, 56:5055-5062.
13. Shiohara M., Akashi M., Gombart A.F., Yang R., Koeffler H.P. Tumor necrosis factor alpha: posttranscriptional stabilization of WAF1 mRNA in p53-deficient human leukemic cells. J. Cell. Physiol. 1996, 166:568-576.
14. Akashi M., Osawa Y., Koeffler H.P., Hachiya M. p21WAF1 expression by an activator of protein kinase C is regulated mainly at the post-transcriptional level in cells lacking p53: important role of RNA stabilization. Biochem. J. 1999, 337(Pt 3):607-616.
15. Liu J., Shen X., Nguyen V.A., Kunos G., Gao B. Alpha(1) adrenergic agonist induction of p21(waf1/cip1) mRNA stability in transfected HepG2 cells correlates with the increased binding of an AU-rich element binding factor. J. Biol. Chem. 2000, 275:11846-11851.
16. Wang W., Furneaux H., Cheng H., Caldwell M.C., Hutter D., Liu Y., Holbrook N., Gorospe M. HuR regulates p21 mRNA stabilization by UV light. Mol. Cell. Biol. 2000, 20:760-769.
17. Giles K.M., Daly J.M., Beveridge D.J., Thomson A.M., Voon D.C., Furneaux H.M., Jazayeri J.A., Leedman P.J. The 3′-untranslated region of p21WAF1 mRNA is a composite cis-acting sequence bound by RNA-binding proteins from breast cancer cells, including HuR and poly(C)-binding protein. J. Biol. Chem. 2003, 278:2937-2946.
18. Yang X., Wang W., Fan J., Lal A., Yang D., Cheng H., Gorospe M. Prostaglandin A2-mediated stabilization of p21 mRNA through an ERK-dependent pathway requiring the RNA-binding protein HuR. J. Biol. Chem. 2004, 279:49298-49306.
19. Joseph B., Orlian M., Furneaux H. p21(waf1) mRNA contains a conserved element in its 3′-untranslated region that is bound by the Elav-like mRNA-stabilizing proteins. J. Biol. Chem. 1998, 273:20511-20516.
20. Lal A., Mazan-Mamczarz K., Kawai T., Yang X., Martindale J.L., Gorospe M. Concurrent versus individual binding of HuR and AUF1 to common labile target mRNAs. EMBO J. 2004, 23:3092-3102.
21. Cho S.J., Zhang J., Chen X. RNPC1 modulates the RNA-binding activity of, and cooperates with, HuR to regulate p21 mRNA stability. Nucleic Acids Res. 2010, 38:2256-2267.
22. Waggoner S.A., Johannes G.J., Liebhaber S.A. Depletion of the poly(C)-binding proteins alphaCP1 and alphaCP2 from K562 cells leads to p53-independent induction of cyclin-dependent kinase inhibitor (CDKN1A) and G1 arrest. J. Biol. Chem. 2009, 284:9039-9049.
23. Shu L., Yan W., Chen X. RNPC1, an RNA-binding protein and a target of the p53 family, is required for maintaining the stability of the basal and stress-induced p21 transcript. Genes Dev. 2006, 20:2961-2972.
24. Dehm S.M., Hilton T.L., Wang E.H., Bonham K. SRC proximal and core promoter elements dictate TAF1 dependence and transcriptional repression by histone deacetylase inhibitors. Mol. Cell. Biol. 2004, 24:2296-2307.
25. Scott G.K., Mattie M.D., Berger C.E., Benz S.C., Benz C.C. Rapid alteration of microRNA levels by histone deacetylase inhibition. Cancer Res. 2006, 66:1277-1281.
26. Lee E.M., Shin S., Cha H.J., Yoon Y., Bae S., Jung J.H., Lee S.M., Lee S.J., Park I.C., Jin Y.W., An S. Suberoylanilide hydroxamic acid (SAHA) changes microRNA expression profiles in A549 human non-small cell lung cancer cells. Int. J. Mol. Med. 2009, 24:45-50.
27. Ivanovska I., Ball A.S., Diaz R.L., Magnus J.F., Kibukawa M., Schelter J.M., Kobayashi S.V., Lim L., Burchard J., Jackson A.L., Linsley P.S., Cleary M.A. MicroRNAs in the miR-106b family regulate p21/CDKN1A and promote cell cycle progression. Mol. Cell. Biol. 2008, 28:2167-2174.
28. Wu S., Huang S., Ding J., Zhao Y., Liang L., Liu T., Zhan R., He X. Multiple microRNAs modulate p21Cip1/Waf1 expression by directly targeting its 3′ untranslated region. Oncogene 2010, 29:2302-2308.
29. Xiong Y., Dowdy S.C., Podratz K.C., Jin F., Attewell J.R., Eberhardt N.L., Jiang S.W. Histone deacetylase inhibitors decrease DNA methyltransferase-3B messenger RNA stability and down-regulate de novo DNA methyltransferase activity in human endometrial cells. Cancer Res. 2005, 65:2684-2689.
30. Januchowski R., Dabrowski M., Ofori H., Jagodzinski P.P. Trichostatin A down-regulate DNA methyltransferase 1 in Jurkat T cells. Cancer Lett. 2007, 246:313-317.
31. Scott G.K., Marx C., Berger C.E., Saunders L.R., Verdin E., Schafer S., Jung M., Benz C.C. Destabilization of ERBB2 transcripts by targeting 3′ untranslated region messenger RNA associated HuR and histone deacetylase-6. Mol. Cancer Res. 2008, 6:1250-1258.
32. Krishnan M., Singh A.B., Smith J.J., Sharma A., Chen X., Eschrich S., Yeatman T.J., Beauchamp R.D., Dhawan P. HDAC inhibitors regulate claudin-1 expression in colon cancer cells through modulation of mRNA stability. Oncogene 2010, 29:305-312.
33. Yoshioka H., Kamitani H., Watanabe T., Eling T.E. Nonsteroidal anti-inflammatory drug-activated gene (NAG-1/GDF15) expression is increased by the histone deacetylase inhibitor trichostatin A. J. Biol. Chem. 2008, 283:33129-33137.